AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 3577821
Drug: Adenosine 0.07
RxNorm normalized name: Niacinamide 3.6 g in 180 mL / Adenosine 0.07 g in 180 mL TOPICAL LIQUID [VITA VOLU VOLUME BOOSTER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 0.07 mg kg‐1 min‐1 following saline
Trial: 3577821
Drug: Adenosine 0.005
RxNorm normalized name: ADENOSINE 0.005 g in 13 mL TOPICAL LIQUID [Tissen ICM 10]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 0.005 mg kg‐1 min‐1 following dipyridamole
Trial: 3577821
Drug: Adenosine 0.08-0.09
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 0.08-0.09 mg kg‐1 min‐1 following saline
Trial: 24045438
Drug: Fibrin sealant
RxNorm normalized name: FIBRIN SEALANT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fibrin sealant (FS) spray
Trial: 20884422
Drug: Intravenous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous enoxaparin 0.75 mg/kg
Trial: 20884422
Drug: Intravenous enoxaparin
RxNorm normalized name: enoxaparin
DrugBank: Enoxaparin (DB01225)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous enoxaparin 0.75 mg/kg in patients with ACS
Trial: 20884422
Drug: Unfractionated heparin
RxNorm normalized name: Unfractionated heparin
DrugBank: Heparin (DB01109)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unfractionated heparin (UFH) in patients with ACS
Trial: 12559642
Drug: Interim analysis
RxNorm normalized name: Chemicals and reagents for analysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interim analysis of a new drug for autoimmune disease
Trial: 7692189
Drug: Granulocyte colony-stimulating
RxNorm normalized name: Granulocyte colony-stimulating factor lenograstim
DrugBank: Lenograstim (DB13144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granulocyte colony-stimulating factor (G-CSF) at 10.5 +/- 1.2 micrograms/kg per day
Trial: 24256166
Drug: 1.5 μg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.5 μg Ni/week
Trial: 17474806
Drug: Duloxetine 120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duloxetine 120 mg
Trial: 16514812
Drug: Lisinopril administration
RxNorm normalized name: Lisinopril
DrugBank: Lisinopril (DB00722)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lisinopril administration
Trial: 9625099
Drug: Elevated AGP
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated AGP (> or = 1 g/L)
Trial: 9625099
Drug: Elevated CRP
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Elevated CRP (> or = 5 mg/L)
Trial: 8170176
Drug: Aspirin preoperatively
RxNorm normalized name: Aspirin
DrugBank: Acetylsalicylic acid (DB00945)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Aspirin preoperatively
Trial: 8170176
Drug: Heparin followed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin followed by warfarin sodium
Trial: 1331724
Drug: Oatbran (60
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oatbran (60 g per day)
Trial: 23837502
Drug: Submerged implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Submerged implant placement
Trial: 23837502
Drug: Transmucosal implant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transmucosal implant placement
Trial: 24409075
Drug: Nedaplatin (NDP)
RxNorm normalized name: Nedaplatin
DrugBank: Nedaplatin (DB13145)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nedaplatin (NDP) 80‐100 mg/m² iv on day 1 + leucovorin (CF) 100 mg/m² iv on days 1‐5 + 5‐fluorouracil (5‐FU) 500 mg/m² iv on days 1‐5
Trial: 22151509
Drug: Oral contraceptives
RxNorm normalized name: VCF Contraceptive
DrugBank: Nonoxynol-9 (DB06804)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral contraceptives (the pill)
Trial: 19393409
Drug: Silver nitrate
RxNorm normalized name: Silver Nitrate
DrugBank: Silver (DB12965)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Silver nitrate cautery followed by antiseptic cream for 4 weeks
Trial: 19393409
Drug: Sham cautery
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham cautery followed by antiseptic cream for 4 weeks
Trial: 17370660
Drug: Telescopic crowns
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Telescopic crowns on two endosseous implants
Trial: 15331202
Drug: Oolong tea
RxNorm normalized name: oolong tea leaf extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oolong tea (1000 ml)
Trial: 8143398
Drug: Inhaled marijuana
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled marijuana smoke (1 marijuana cigarette containing 1.54% delta 9‐tetrahydrocannabinol)
Trial: 8143398
Drug: Inhaled marijuana
RxNorm normalized name: Picea mariana resin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled marijuana smoke
Trial: 2895664
Drug: sublingual lormetazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sublingual lormetazepam 2.5 mg
Trial: 2895664
Drug: i.v. diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. diazepam 10 mg
Trial: 30656849
Drug: Ethanol treatment
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethanol treatment
Trial: 28939223
Drug: Stereotactic radiosurgery
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stereotactic radiosurgery (SRS) + Whole-brain radiation therapy (WBRT)
Trial: 23617135
Drug: Traditional restoration
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Traditional restoration methods with traction treatment
Trial: 18547177
Drug: NASHA 100,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NASHA 100,000 gel particles/mL filler with retreatment at 4.5 months
Trial: 18547177
Drug: NASHA 100,000
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NASHA 100,000 gel particles/mL filler with retreatment at 9 months
Trial: 29515036
Drug: Omeprazole treatment
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole treatment for 14 days
Trial: 7871380
Drug: Triple therapy
RxNorm normalized name: MigreLief Triple Therapy with Puracol Caplet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triple therapy (bismuth subnitrate, oxytetracycline, metronidazole) for 2 weeks
Trial: 3370308
Drug: Furosemide 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 40 mg as aqueous solution
Trial: 3370308
Drug: Furosemide 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 40 mg as Tablet A (fast dissolution)
Trial: 3370308
Drug: Furosemide 40
RxNorm normalized name: furosemide 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide 40 mg as Tablet B (slow dissolution)
Trial: 3370308
Drug: Furosemide tablets
RxNorm normalized name: Furosemide Tablets
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide tablets (both A and B)
Trial: 26860016
Drug: Lactated Ringer's
RxNorm normalized name: LACTATED RINGER'S
DrugBank: Sodium chloride (DB09153)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lactated Ringer's solution at a 'keep vein open' rate (Group E)
Trial: 23325481
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride XR 60 mg once daily for 10 days plus metformin 500 mg twice daily for 3.5 days
Trial: 23325481
Drug: Metformin 500
RxNorm normalized name: metformin 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin 500 mg twice daily for 3.5 days
Trial: 23325481
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride XR 60 mg once daily for 10 days
Trial: 23325481
Drug: Trospium chloride
RxNorm normalized name: Trospium Chloride
DrugBank: Trospium (DB00209)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Trospium chloride XR and metformin coadministration
Trial: 19858754
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (electrotherapies and lumbar strengthening exercises)
Trial: 15205566
Drug: 600 mg/day
RxNorm normalized name: Rebetron, single dose 600 mg/day oral and injectable kit
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg/day vaginal micronized progesterone (group I)
Trial: 15205566
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol 100 microg/day + 600 mg/day vaginal micronized progesterone (group II)
Trial: 11502994
Drug: Losartan (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (50 mg/day) for 8 weeks
Trial: 11502994
Drug: Enalapril (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril (10 mg/day) for 8 weeks
Trial: 9113812
Drug: Cisapride 20
RxNorm normalized name: cisapride 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 20 mg tid
Trial: 9113812
Drug: Cisapride 10
RxNorm normalized name: cisapride 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cisapride 10 mg tid
Trial: 8256900
Drug: Corticosteroid (CS)
RxNorm normalized name: MyoGesic-CS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid (CS) therapy with methylprednisolone
Trial: 3839972
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g sucralfate twice a day
Trial: 3839972
Drug: 1 g
RxNorm normalized name: Molds 1 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 g sucralfate four times a day
Trial: 22645114
Drug: Endoscopic DCR
RxNorm normalized name: DCR-PHXC free acid
DrugBank: Nedosiran (DB17635)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic DCR with mitomycin C (0.5 mg/mL applied for 10 minutes)
Trial: 20728414
Drug: Acupuncture as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture as part of a Traditional Chinese Medicine (TCM) package
Trial: 20728414
Drug: Acupuncture as
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture as a monotherapy
Trial: 7609169
Drug: Alarm therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alarm therapy
Trial: 17919550
Drug: PHX1149 single-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHX1149 single-dose (50 to 500 mg)
Trial: 17919550
Drug: PHX1149 multiple-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PHX1149 multiple-dose (50 to 400 mg QD for 13 days)
Trial: 16053461
Drug: Sertraline (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sertraline (20 mg/day)
Trial: 16053461
Drug: Alprazolam (1-1.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alprazolam (1-1.5 mg/day)
Trial: 12352513
Drug: Standard formula
RxNorm normalized name: Standard formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard formula with a protein/energy ratio of 2.2 g/100 kcal
Trial: 12352513
Drug: Formula with
RxNorm normalized name: Stress B Formula with C
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula with a protein/energy ratio of 1.8 g/100 kcal
Trial: 10597955
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplement 1.0 mg
Trial: 10597955
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid supplement 2.5 mg
Trial: 10597956
Drug: No folic
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: No folic acid supplement
Trial: 9798800
Drug: UDCA 10
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 10 mg/kg/day
Trial: 10075964
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of simvastatin and UDCA
Trial: 1992600
Drug: nilutamide (Anandron),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nilutamide (Anandron), 100 mg t.i.d. with orchiectomy
Trial: 18414360
Drug: Propofol (0.4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propofol (0.4 mg/kg)
Trial: 25574984
Drug: Normal Saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal Saline (3 ml)
Trial: 22491350
Drug: Acute alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute alcohol administration (0.8 g/kg)
Trial: 20389159
Drug: Sirolimus, low-dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sirolimus, low-dose tacrolimus, and steroids (Group A)
Trial: 20389159
Drug: Sirolimus, mycophenolate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sirolimus, mycophenolate mofetil, and steroids (Group B)
Trial: 12457449
Drug: Dual-fortified salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dual-fortified salt (iodine 25 microg/g salt and iron 1 mg/g salt)
Trial: 12457449
Drug: Iodized salt
RxNorm normalized name: calcium iodized
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Iodized salt (25 microg iodine/g salt)
Trial: 8596499
Drug: Resistance exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance exercise training (RE) + recombinant human growth hormone (rhGH)
Trial: 8596499
Drug: Resistance exercise
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Resistance exercise training (RE) or hormone treatment
Trial: 1749302
Drug: Adjuvant chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant chemotherapy with folinic acid, 5-Fluorouracil (FU) and mitomycin C (MMC)
Trial: 7044606
Drug: Control (Medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Medical treatment)
Trial: 30817778
Drug: All biomarkers
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All biomarkers measured at Day 1 (except urinary L-FABP)
Trial: 26341963
Drug: Botanicals with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botanicals with anticonvulsant properties
Trial: 21308609
Drug: Hypertonic sodium
RxNorm normalized name: Sodium Chloride Topical application Dressing [CURITY HYPERTONIC SODIUM CHLORIDE PACKING STRIP]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypertonic sodium chloride solution (3% NaCl)
Trial: 21308609
Drug: Isotonic salt
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic salt solution (0.9% NaCl)
Trial: 19084860
Drug: Combined perianal‐intrarectal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined perianal‐intrarectal lidocaine‐prilocaine cream and periprostatic nerve block (group 1)
Trial: 19084860
Drug: Perianal‐intrarectal lidocaine‐prilocaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perianal‐intrarectal lidocaine‐prilocaine cream alone (group 2)
Trial: 17463297
Drug: High sodium
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High sodium beverage (164 mmol Na(+)/l)
Trial: 17463297
Drug: Low sodium
RxNorm normalized name: Slow Sodium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low sodium beverage (10 mmol Na(+)/l)
Trial: 28860046
Drug: IVB (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVB (2.5 mg/0.1 mL) administered 5-10 days before PPV (Group B)
Trial: 28860046
Drug: IVB (2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVB (2.5 mg/0.1 mL) administered 1-3 days before PPV (Group A)
Trial: 17535636
Drug: Nutritional remedy
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional remedy with the dipeptide of glutamine and alanine (Group G)
Trial: 17535636
Drug: Routine nutritional
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine nutritional therapy only (Group C)
Trial: 15070913
Drug: 20K-hGH 0.006
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20K-hGH 0.006 mg/kg.d
Trial: 15070913
Drug: 20K-hGH 0.012
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20K-hGH 0.012 mg/kg.d
Trial: 15070913
Drug: 20K-hGH 0.024
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20K-hGH 0.024 mg/kg.d
Trial: 9428488
Drug: Breast-conserving therapy
RxNorm normalized name: chicken breast preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breast-conserving therapy (BCT) including excisional biopsy and postoperative external beam irradiation (45-50 Gy to the whole breast and a boost to the tumor bed to at least 60 Gy)
Trial: 28158558
Drug: Step Care
RxNorm normalized name: PostDay One-Step
DrugBank: Levonorgestrel (DB00367)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Step Care intervention (single counseling session, nicotine patch for six weeks, telephonic contact)
Trial: 28158558
Drug: Recycle intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Recycle intervention (one session of health behavior counseling, nicotine patch for six weeks, telephone call at each step)
Trial: 21334613
Drug: recombinant FSH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant FSH (50‐150 IU/d) plus ganirelix (0.25 mg/d)
Trial: 14755132
Drug: lamotrigine (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lamotrigine (300 mg per os)
Trial: 11389707
Drug: lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lovastatin 20 mg/d
Trial: 9268795
Drug: Morphine sulfate
RxNorm normalized name: Morphine Sulfate
DrugBank: Morphine (DB00295)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Morphine sulfate (5 mg)
Trial: 9268795
Drug: Bupivacaine (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (50 mg)
Trial: 9268795
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of morphine sulfate and bupivacaine
Trial: 8299668
Drug: Inhaled frusemide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled frusemide (F)
Trial: 8299668
Drug: Inhaled bumetanide
RxNorm normalized name: Bumetanide
DrugBank: Bumetanide (DB00887)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled bumetanide (B)
Trial: 3202502
Drug: Inhaled salbutamol
RxNorm normalized name: salbutamol
DrugBank: Albuterol (DB01001)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Inhaled salbutamol (S)
Trial: 31641769
Drug: Bedtime hypertension
RxNorm normalized name: Buckley's Bedtime Formula
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bedtime hypertension treatment (n=9552)
Trial: 31641769
Drug: Upon awakening
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Upon awakening hypertension treatment (n=9532)
Trial: 22643725
Drug: Interferential light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential light therapy with two independent cluster probes (n = 15)
Trial: 22643725
Drug: Conventional light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional light therapy with one active probe (n = 15)
Trial: 10639529
Drug: 300 mg
RxNorm normalized name: rutin 300 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg mexiletine
Trial: 8628358
Drug: C1 inhibitor
RxNorm normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C1 inhibitor (25 plasma units per kilogram of body weight)
Trial: 8628358
Drug: C1 inhibitor
RxNorm normalized name: C1 INHIBITOR
DrugBank: Conestat alfa (DB09228)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: C1 inhibitor (25 plasma units per kilogram)
Trial: 1324529
Drug: Intravenous immunoglobulin
RxNorm normalized name: Intravenous immunoglobulin (IVIg)
DrugBank: Human immunoglobulin G (DB00028)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous immunoglobulin (IVIG) products
Trial: 26558434
Drug: Amlodipine oral
RxNorm normalized name: amlodipine Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine oral solution 0.5 mg/mL
Trial: 26558434
Drug: Norvasc® 5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Norvasc® 5 mg tablets
Trial: 22127561
Drug: Isotonic sodium
RxNorm normalized name: ISOTONIC SODIUM CHLORIDE SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isotonic sodium bicarbonate infusion
Trial: 22127561
Drug: Placebo infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo infusion (isotonic saline)
Trial: 22127561
Drug: Both trials
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both trials (Isotonic sodium bicarbonate infusion and Placebo infusion)
Trial: 15827359
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of expert and self videotape feedback
Trial: 8550362
Drug: Sumatriptan 100
RxNorm normalized name: sumatriptan 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sumatriptan 100 mg tid for 7 days
Trial: 339659
Drug: Clonidine 75
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 75 microgram twice daily
Trial: 31650795
Drug: β-caryophyllene (126
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β-caryophyllene (126 mg/day)
Trial: 16854755
Drug: Zinc/clindamycin gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zinc/clindamycin gel (Zindaclin 1%)
Trial: 16854755
Drug: Clindamycin lotion
RxNorm normalized name: clindamycin Topical Lotion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clindamycin lotion (Dalacin T)
Trial: 11170778
Drug: Nutrison Packs
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutrison Packs (2 x 1000 mL triple foil laminated pouches)